ARTICLE SUMMARY:
Sepsis becomes deadly very quickly, but current diagnostics are slow to detect it. ImpeDx has a new platform for diagnosing bacteremia faster by taking advantage of the electrical capacitance of pathogens.
ImpeDx Diagnostics Inc. is Steve O’Connor’s eleventh start-up. With a PhD in physical chemistry from Caltech, he’s a named inventor on more than 50 US patents, many of them in life science fields.
